Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL16791 | BROADPEAK | ||||||
GSE99669 |
The 8p11-p12 amplicon oncogene ASH2L regulates expression of genes involved in tumorigenic processes via promoter H3K4me3 in luminal breast cancer. (SUM-44 ASH2L knockdown H3K4me3 ChIP-seq)
|
12 |
|
Gary Hardiman | May 24, 2024 | |||
GSE239481 |
Defining Cis-regulatory Elements and Transcription Factors that Control Human Cortical Interneuron Development
|
118 |
|
Kristen Kroll | Apr 17, 2024 | |||
GSE241444 |
XIST directly regulates X-linked and autosomal genes in naïve human pluripotent cells
|
129 |
|
Kathrin Plath | Dec 13, 2023 | |||
GSE248980 |
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
|
40 |
|
Ruben Schep | Nov 30, 2023 | |||
GSE235745 |
Dynamic enhancer landscapes in human craniofacial development [human ChIP]
|
7 |
|
Laura E Cook | Sep 11, 2023 | |||
GSE235858 |
Dynamic enhancer landscapes in human craniofacial development
|
67 |
|
Laura E Cook | Sep 11, 2023 | |||
GSE241450 |
Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers
|
119 |
|
Salih Topal | Sep 11, 2023 | |||
GSE221046 |
Transposable elements as lineage-specific enhancers in endodermal-lineage cancers (ChIP-Seq)
|
7 |
|
Konsta Karttunen | Aug 11, 2023 | |||
GSE221053 |
Transposable elements as lineage-specific enhancers in endodermal-lineage cancers
|
30 |
|
Konsta Karttunen | Aug 11, 2023 | |||
GSE210220 |
Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation
|
5 | Yueyuan Zheng | Aug 04, 2023 | ||||
GSE210858 |
MAF functions as a pioneer transcription factor that initiates and sustains oncogenesis
|
49 | Nikolaos Trasanidis | Aug 01, 2023 | ||||
GSE223834 |
Integrative genome-wide analysis of PBMCs confirmed SOD1-specific functionality of ATF3 in ALS blood
|
11 | Karin M Danzer | Jul 01, 2023 | ||||
GSE227025 |
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
|
10 |
|
Xiaoping Su | Jun 14, 2023 | |||
GSE222571 |
Haploinsufficiency of NFKBIA reshapes the epigenome and imparts disease fate in diffuse gliomas
|
6 |
|
Lluis Espinosa | Apr 28, 2023 | |||
GSE210277 |
Synthetic epigenetic reprogramming of mesenchymal to epithelial states using the CRISPR/dCas9 platform in triple negative breast cancer
|
45 |
|
Joe Cursons | Apr 17, 2023 | |||
GSE182017 |
Pluripotency-Independent Induction of Human Trophoblast Stem Cells from Fibroblasts
|
114 |
|
Yosef Buganim | Feb 21, 2023 | |||
GSE213533 |
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer
|
16 |
|
Serap Erkek Özhan | Feb 20, 2023 | |||
GSE181829 |
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes
|
71 |
|
Mark Dawson | Jan 13, 2023 | |||
GSE207401 |
DNA elements tether canonical Polycomb Repressive Complex 1 to human genes
|
32 | Yuri Schwartz | Jan 13, 2023 | ||||
GSE181015 |
ERK signalling orchestrates neural differentiation by promoting the polycomb repressive complex.
|
47 |
|
Kate G Storey | Sep 16, 2022 |